Standort der Organisation:
Stuttgart, Deutschland

Publikationen in Kooperation mit FAU-Wissenschaftern

Go to first page Go to previous page 1 von 4 Go to next page Go to last page
Buettner, F., Winter, S., Rausch, S., Hennenlotter, J., Kruck, S., Stenzl, A.,... Schaeffeler, E. (2019). Clinical utility of the simplified 15-gene S3-score for prediction of outcome in clear cell renal cell carcinoma. In NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Stuttgart, GERMANY, DE: NEW YORK: SPRINGER.
Fox, K., Achenbach, S., Bax, J., Cosyns, B., Delgado, V., Dweck, M.R.,... Popescu, B.A. (2019). Multimodality imaging in cardiology: a statement on behalf of the Task Force on Multimodality Imaging of the European Association of Cardiovascular Imaging. European Heart Journal, 40(6), 553-558.
Middeke, J.M., Rollig, C., Kramer, M., Kramer, A., Bochtler, T., Scholl, S.,... Stoelzel, F. (2018). Clinical Characteristics and Outcome in IDH1/2 Mutant AML Patients - Analysis of 3898 Newly Diagnosed Patients with Acute Myeloid Leukemia. In BLOOD. San Diego, CA, US: WASHINGTON: AMER SOC HEMATOLOGY.
Buettner, F., Winter, S., Rausch, S., Hennenlotter, J., Kruck, S., Stenzl, A.,... Schaeffeler, E. (2018). Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma. Bmc Medicine, 16(1).
Wermann, W.K., Viardot, A., Kayser, S., Alakel, N., Elmaagacli, A., Faul, C.,... Goekbuget, N. (2018). Comorbidities Are Frequent in Older Patients with De Novo Acute Lymphoblastic Leukemia (ALL) and Correlate with Induction Mortality: Analysis of More Than 1200 Patients from GMALL Data Bases. In BLOOD. San Diego, CA, US: WASHINGTON: AMER SOC HEMATOLOGY.
Hammad, S., Othman, A., Meyer, C., Telfah, A., Lambert, J., Dewidar, B.,... Dooley, S. (2018). Confounding influence of tamoxifen in mouse models of Cre recombinase-induced gene activity or modulation. Archives of Toxicology, 92(8), 2549-2561.
Stasik, S., Middeke, J.M., Kraemer, M., Rollig, C., Kramer, A., Scholl, S.,... Thiede, C. (2018). EZH2 Mutations and Impact on Clinical Outcome Analyzed in 1604 Patients with Acute Myeloid Leukemia. In BLOOD. San Diego, CA, US: WASHINGTON: AMER SOC HEMATOLOGY.
O'Mara, T.A., Glubb, D.M., Amant, F., Annibali, D., Ashton, K., Attia, J.,... Thompson, D.J. (2018). Identification of nine new susceptibility loci for endometrial cancer. Nature Communications, 9(1).
Schanz, M., Schanz, M., Schricker, S., Pfister, F., Alscher, M.D., Alscher, M.D., & Kimmel, M. (2018). Renal complications of cancer therapies. Drugs of Today, 54(9), 561-575.
Heidrich, K., Thiede, C., Schaefer-Eckart, K., Schmitz, N., Aulitzky, W.E., Kraemer, A.,... Schetelig, J. (2017). Allogeneic Hematopoietic Cell Transplantation in Intermediate Risk Acute Myeloid Leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA Mutations. Annals of Oncology.
Weiss, T.S., Lupke, M., Ibrahim, S., Buechler, C., Lorenz, J., Ruemmele, P.,... Dayoub, R. (2017). Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways. PLoS ONE, 12(9), e0184282.
Breitkopf-Heinlein, K., Meyer, C., Koenig, C., Gaitantzi, H., Addante, A., Thomas, M.,... Ten Dijke, P. (2017). BMP-9 interferes with liver regeneration and promotes liver fibrosis. Gut, 66(5), 939-954.
Shimelis, H., Mesman, R.L.S., Von Nicolai, C., Ehlen, A., Guidugli, L., Martin, C.,... Couch, F.J. (2017). BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. Cancer Research, 77(11), 2789-2799.
Salb, J., Lindemann, U., Woodward, C., Almuhtaseb, S., Becker, C., Sieber, C., & Freiberger, E. (2017). Gait Analysis in Adults with Intellectual Disabilities Living in a Residential Facility. Journal of Applied Research in Intellectual Disabilities, 30(1), 205-210.
Belharazem, D., Grass, A., Paul, C., Vitacolonna, M., Schalke, B., Rieker, R.,... Marx, A. (2017). Increased cFLIP expression in thymic epithelial tumors blocks autophagy via NF-κB signalling. Oncotarget, 8(52), 89580-89594.
Jiao, X., Aravidis, C., Marikkannu, R., Rantala, J., Picelli, S., Adamovic, T.,... Lindblom, A. (2017). PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. Oncotarget, 8(61), 102769-102782.
Häberle, L., Hein, A., Rübner, M., Schneider, M., Ekici, A.B., Gaß, P.,... Wunderle, M. (2017). Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods. Geburtshilfe und Frauenheilkunde, 77(6), 667-678.
Brouckaert, O., Rudolph, A., Laenen, A., Keeman, R., Bolla, M.K., Wang, Q.,... Neven, P. (2017). Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. Breast Cancer Research, 19(1).
Ho, A.D., Schetelig, J., Bochtler, T., Schaich, M., Schaefer-Eckart, K., Haenel, M.,... Ehninger, G. (2016). Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITD. Biology of Blood and Marrow Transplantation, 22(3), 462-9.
Wyszynski, A., Hong, C.-C., Lam, K., Michailidou, K., Lytle, C., Yao, S.,... Cole, M.D. (2016). An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. Human Molecular Genetics, 25(17), 3863-3876.

Zuletzt aktualisiert 2016-22-04 um 08:09